同时患有糖尿病和支气管喘的患者的甲福明使用和喘结果:系统性审查和元分析
A B M Kamrul-Hasan1, Joseph M Pappachan2,3,4, Parth Jethwani5
1Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh.
The Indian journal of medical research
|October 16, 2025
概括
在患有喘的2型糖尿病患者中使用甲福明并没有显著改变喘恶化或整体住院情况. 然而,排除一项研究表明了潜在的益处,这需要谨慎解释和进一步研究.
科学领域:
- 肺部医学 肺部医学
- 内分泌学 在内分泌学.
- 临床药房 临床药房
背景情况:
- 关于甲福明对2型糖尿病 (T2D) 患者喘结果的影响的数据有限.
- 这一元分析调查了甲胺对喘恶化和相关医疗保健利用的影响.
研究的目的:
- 为了确定甲福明的使用是否会影响T2D患者喘恶化风险.
- 评估与喘相关的其他结果,包括急诊,住院和类固醇使用.
主要方法:
- 在T2D和喘患者中,系统搜索比较甲胺使用者 (MU) 与非甲胺使用者 (非MU) 的研究.
- 使用随机效应模型的元分析,报告危险比率 (HRs) 和95%置信区间 (95%CI).
- 主要结局:喘恶化的调整风险;次要结局:急诊室访问,住院治疗,救援类固醇使用.
主要成果:
- 总的来说,MU和非MU之间喘恶化风险没有显著差异 (HR 0.95,95% CI:0.861.04).
- 在急诊室访问的减少趋势 (HR 0.63,95% CI: 0.391.01) 和住院治疗 (HR 0.76,95% CI: 0.541.07) 和类固醇使用 (HR 0.95,95% CI: 0.871.03) 的非显著差异.
- 除了一项台湾研究外,MU.的恶化 (HR 0.89,95% CI:0.830.97) 和住院 (HR 0.68,95% CI:0.490.93) 的风险显著降低.
结论:
- 对T2D的梅特福林治疗似乎没有影响整体喘结果.
- 排除一个特定的研究表明,在某些喘结局上,甲福明的潜在益处需要谨慎的解释.
- 观察性质和中等偏差风险需要随机对照试验来得出关于甲福林和喘结果的最终结论.
更多相关视频
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
20.1K
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14.7K
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
582
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
582
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:24Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722